Critical appraisal of commercially available suspending vehicles for extemporaneous compounding of cardiovascular medicines: physical and chemical stability mini review

Thrimawithana, T, D'Amore, S, Dib, Y, Fadavi Firooz, N, Fakhouri, W, Saeed, A and Allahham, A 2018, 'Critical appraisal of commercially available suspending vehicles for extemporaneous compounding of cardiovascular medicines: physical and chemical stability mini review', Pharmaceutical Development and Technology, vol. 24, no. 5, pp. 529-538.


Document type: Journal Article
Collection: Journal Articles

Title Critical appraisal of commercially available suspending vehicles for extemporaneous compounding of cardiovascular medicines: physical and chemical stability mini review
Author(s) Thrimawithana, T
D'Amore, S
Dib, Y
Fadavi Firooz, N
Fakhouri, W
Saeed, A
Allahham, A
Year 2018
Journal name Pharmaceutical Development and Technology
Volume number 24
Issue number 5
Start page 529
End page 538
Total pages 10
Publisher Taylor and Francis
Abstract Oral liquid formulations are compounded by pharmacists to meet the needs of patients when a suitable commercially available product is not available. To minimise the errors associated with measuring multiple excipients and to enhance the shelf-life of the medicines, commercially available suspending bases are commonly used. This review aims to compare the stability and shelf life of commercially available extemporaneous formulation to traditional formulation methods. Five (5) databases were searched (Pubmed, SCOPUS, Science direct, Embase and EBSCOhost). Twelve articles, comprising of seven cardiovascular medications (amiodarone, captopril, carvedilol, furosemide, nifedipine, sotalol and valsartan), met the study inclusion criteria and were reviewed. Chemical stability of the drugs was comparable between the two formulation methods except for furosemide, captopril and valsartan. The traditional compounding method provided superior stability for furosemide (90 days vs 14 days) and captopril (50 days vs 14 days), while the commercial vehicles provided superior stability for valsartan (90 days vs 14 days). Physical stability tests indicated that sedimentation does occur with both formulation methods. Microbial studies within the data were lacking and further research can be undertaken in this area. This review highlights the importance of assessing the suitability of compounding ingredients prior to preparation of the formulation.
Subject Clinical Pharmacy and Pharmacy Practice
Keyword(s) Extemporaneous compounding
Stability
Oral liquid
Amiodarone
Captopril
Furosemide
Carvedilol
Sotalol
Nifedipine
Valsartan
DOI - identifier doi.org/10.1080/10837450.2018.1526955
Copyright notice © 2018 Informa UK Limited, trading as Taylor & Francis Group
ISSN 1097-9867
Versions
Version Filter Type
Citation counts: Scopus Citation Count Cited 0 times in Scopus Article
Altmetric details:
Access Statistics: 13 Abstract Views  -  Detailed Statistics
Created: Thu, 31 Jan 2019, 11:26:00 EST by Catalyst Administrator
© 2014 RMIT Research Repository • Powered by Fez SoftwareContact us